Patients with severe infantile-onset Pompe disease can be differentiated into two groups: one group with detectable GAA protein (Cross Reactive Immunologic Material Positive, CRIM+) and another group without any detectable GAA protein (Cross Reactive Immunologic Material Negative, CRIM−). Here, GAA is linked to Onset.